Methods for evaluating novel biomarkers - A new paradigm

International Journal of Clinical Practice

Volumn 64, Issue 13, 2010, Pages 1723-1727

  Cook, N R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AREA UNDER THE CURVE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; EVALUATION; HUMAN; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; STATISTICS; SWEDEN; SYSTOLIC BLOOD PRESSURE;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 78649286115     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02469.x     Document Type: Review

References (16)

1. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355: 2631 - 9.
2. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302: 49 - 57.
3. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29 - 36.
4. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P,. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159: 882 - 90.
5. Cook NR,. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115: 928 - 35.
6. Cook NR, Ridker PM,. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 2009; 150: 795 - 802.
7. Pencina MJ, D'Agostino RBS, D'Agostino RBJ, Vasan RS,. Evaluating the added predictive ability of a new biomarker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157 - 72.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486 - 97.
9. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293 - 304.
10. Ridker PM, Buring JE, Rifai N, Cook NR,. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. JAMA 2007; 297: 611 - 9.
11. Steyerberg EW, Pencina MJ,. Reclassification calculations for persons with incomplete follow-up (letter). Ann Intern Med 2010; 152: 195 - 196.
12. Pepe MS, Feng Z, Gu JW,. Comments on 'Evaluating the added predictive ability of a new biomarker: from area under the ROC curve to reclassification and beyond'. Stat Med 2008; 27: 173 - 81.
13. Moons KGM, Harrell FE,. Sensitivity and specificity should be de-emphasized in diagnostic accuracy studies. Acad Radiol 2003; 10: 670 - 2.
14. Cook NR,. Biomarkers for predicition of cardiovascular events (letter). JAMA 2009; 302: 2089.
15. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR,. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008; 118: 2243 - 51.
16. Wilson PWF, Pencina M, Jacques P, Selhub J, D'Agostino R, O'Donnell CJ,. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 2008; 1: 92 - 7.